TumorNext-Lynch™ Helps Clinicians Diagnose Lynch Syndrome | Ambry Genetics

Learn more: http://www.ambrygen.com/clinic....ian/genetic-testing/

In this video, Jessica Profato, MS, CGC explains how TumorNext-Lynch helps clinicians overcome the challenge of frequent discrepancies between tumor screening and germline testing results when diagnosing Lynch syndrome.

When you need to rule out or confirm Lynch syndrome or to determine if your patient can start PD-LI or PD-1 immunotherapy you need a test that gives you the most comprehensive and accurate information. TumorNext-Lynch is a single test that looks at both tumor and germline mutations, giving you clearer information to better guide treatment decisions.